PRSS2, serine protease 2, 5645

N. diseases: 66; N. variants: 14
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0030305
Disease: Pancreatitis
Pancreatitis
0.140 Biomarker disease HPO
CUI: C0000737
Disease: Abdominal Pain
Abdominal Pain
0.120 Biomarker phenotype BEFREE The trypsinogen-2 dipstick test was positive in 57 of 78 patients with acute pancreatitis (sensitivity, 73.1%) and in 6 of 16 patients with abdominal pain but without any evidence of acute pancreatitis (specificity, 62.5%). 30643362 2019
CUI: C0000737
Disease: Abdominal Pain
Abdominal Pain
0.120 Biomarker phenotype BEFREE It is important to know the diagnostic accuracy of serum amylase, serum lipase, urinary trypsinogen-2, and urinary amylase for the diagnosis of acute pancreatitis, so that an informed decision can be made as to whether the person with abdominal pain has acute pancreatitis. 28431198 2017
CUI: C0000737
Disease: Abdominal Pain
Abdominal Pain
0.120 Biomarker phenotype HPO
CUI: C0376670
Disease: Pancreatitis, Alcoholic
Pancreatitis, Alcoholic
0.100 GeneticVariation disease GWASCAT Genome-wide association study identifies inversion in the CTRB1-CTRB2 locus to modify risk for alcoholic and non-alcoholic chronic pancreatitis. 28754779 2018
CUI: C2985280
Disease: Blood Protein Measurement
Blood Protein Measurement
0.100 GeneticVariation phenotype GWASCAT Genomic atlas of the human plasma proteome. 29875488 2018
CUI: C0011849
Disease: Diabetes Mellitus
Diabetes Mellitus
0.100 Biomarker group HPO
CUI: C0015967
Disease: Fever
Fever
0.100 Biomarker phenotype HPO
CUI: C0022346
Disease: Icterus
Icterus
0.100 Biomarker phenotype HPO
CUI: C0023518
Disease: Leukocytosis
Leukocytosis
0.100 Biomarker phenotype HPO
CUI: C0030299
Disease: Pancreatic Pseudocyst
Pancreatic Pseudocyst
0.100 Biomarker disease HPO
CUI: C0032227
Disease: Pleural effusion disorder
Pleural effusion disorder
0.100 Biomarker group HPO
CUI: C0038238
Disease: Steatorrhea
Steatorrhea
0.100 Biomarker phenotype HPO
CUI: C0267963
Disease: Exocrine pancreatic insufficiency
Exocrine pancreatic insufficiency
0.100 Biomarker disease HPO
CUI: C1842406
Disease: Pancreatic calcification
Pancreatic calcification
0.100 Biomarker phenotype HPO
CUI: C4022560
Disease: Splanchnic vein thrombosis
Splanchnic vein thrombosis
0.100 Biomarker disease HPO
CUI: C4022922
Disease: Abnormal enzyme/coenzyme activity
Abnormal enzyme/coenzyme activity
0.100 Biomarker phenotype HPO
CUI: C4023452
Disease: Elevated C-reactive protein level
Elevated C-reactive protein level
0.100 Biomarker phenotype HPO
CUI: C4025731
Disease: Abnormal thrombosis
Abnormal thrombosis
0.100 Biomarker disease HPO
CUI: C4551632
Disease: Recurrent pancreatitis
Recurrent pancreatitis
0.100 Biomarker disease HPO
CUI: C0001339
Disease: Acute pancreatitis
Acute pancreatitis
0.070 GeneticVariation disease BEFREE The results of pooled analyses showed that CLDN2 rs7057398, MORC4 rs12688220 and PRSS1-PRSS2 rs10273639 polymorphisms were all significantly associated with susceptibility to acute pancreatitis in Caucasians. 31163246 2020
CUI: C0001339
Disease: Acute pancreatitis
Acute pancreatitis
0.070 Biomarker disease BEFREE The trypsinogen-2 dipstick test was positive in 57 of 78 patients with acute pancreatitis (sensitivity, 73.1%) and in 6 of 16 patients with abdominal pain but without any evidence of acute pancreatitis (specificity, 62.5%). 30643362 2019
CUI: C0001339
Disease: Acute pancreatitis
Acute pancreatitis
0.070 Biomarker disease BEFREE In a prospective cohort, urinary trypsinogen-2 level > 500 μg/L independently predicted local complications of AP. 31039289 2019
CUI: C0001339
Disease: Acute pancreatitis
Acute pancreatitis
0.070 GeneticVariation disease BEFREE Here we analysed whether common variants in the CLDN2-MORC4 and the PRSS1-PRSS2 locus that increase recurrent AP and CP risk associate with AP. 29884332 2018
CUI: C0001339
Disease: Acute pancreatitis
Acute pancreatitis
0.070 AlteredExpression disease BEFREE Compared with the AP group, the AP+PD98059+siRNA group had decreased expression of DUSP1 in tissues, whereas the AP+PD98059 group had decreased serum expression levels of TNF‑α, IL‑1β, IL‑6, HMGB1, S100A12 and amylase, lipase and urinary trypsinogen‑2. 29393354 2018